Trends of primary liver cancer incidence and mortality in the United States: A population-based study over the last four decades
- PMID: 39236039
- PMCID: PMC11376511
- DOI: 10.1371/journal.pone.0309465
Trends of primary liver cancer incidence and mortality in the United States: A population-based study over the last four decades
Abstract
Background: Primary liver cancer is the third leading cause of cancer deaths worldwide and has one of the worst 5-year survival rates. This study examines US primary liver cancer incidence and incidence-based mortality trends over four decades.
Research design and methods: The SEER-9 registry was used to study primary liver cancer cases from 1978 to 2018. The incidence and mortality rates were calculated based on gender, age, race, and stage of diagnosis. Joinpoint regression software was used to calculate the annual percent change.
Results: The overall incidence rate of primary liver cancer from 1978 to 2018 increased by 2.71%/year (p<0.001). Rates in patients <50 years old began to fall in 2002 at a rate of -3.62%/year (p<0.001). Similarly, the incidence-based mortality rates for primary liver cancer increased by 2.15%/year (p<0.001). Whereas Whites incidence-based mortality rates began to plateau in 2012 (0.18%/year; p = 0.84), Blacks rates have declined since 2010 (-2.93%/year; p = 0.03), and Asian rates have declined since 1999 (-1.30%/year; p<0.001).
Conclusion: While the overall primary liver cancer incidence and incidence-based mortality have been increasing over the last four decades, there was an observed decline in incidence and incidence-based mortality in recent years, especially among at-risk subgroups.
Copyright: © 2024 Adra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.BMC Cancer. 2018 Jun 25;18(1):688. doi: 10.1186/s12885-018-4610-4. BMC Cancer. 2018. PMID: 29940910 Free PMC article.
-
Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades.Expert Rev Hematol. 2023 Jul-Dec;16(10):785-791. doi: 10.1080/17474086.2023.2243385. Epub 2023 Aug 1. Expert Rev Hematol. 2023. PMID: 37515515
-
Multiple myeloma incidence, mortality, and survival differences at the intersection of sex, age, and race/ethnicity: A comparison between Puerto Rico and the United States SEER population.Cancer Epidemiol. 2024 Apr;89:102537. doi: 10.1016/j.canep.2024.102537. Epub 2024 Jan 31. Cancer Epidemiol. 2024. PMID: 38295555
-
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2019;48(1):5-23. doi: 10.17849/insm-48-1-1-19.1. Epub 2019 Oct 14. J Insur Med. 2019. PMID: 31609640
-
Cancers with increasing incidence trends in the United States: 1999 through 2008.CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28. doi: 10.3322/caac.20141. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22281605 Review.
Cited by
-
Macrotrabecular-Massive Hepatocellular Carcinoma: A Case Report.Cureus. 2024 Dec 19;16(12):e75989. doi: 10.7759/cureus.75989. eCollection 2024 Dec. Cureus. 2024. PMID: 39835031 Free PMC article.
-
Prognostic predictive value of the preoperative systemic immunoinflammatory index combined with the neutrophil-to-lymphocyte ratio in patients with primary liver cancer undergoing transarterial chemoembolization.Oncol Lett. 2025 Jun 27;30(3):414. doi: 10.3892/ol.2025.15160. eCollection 2025 Sep. Oncol Lett. 2025. PMID: 40630711 Free PMC article.
-
Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer Incidence, Mortality in the United States.Am J Gastroenterol. 2024 Nov 12;120(6):1367-1380. doi: 10.14309/ajg.0000000000003198. Am J Gastroenterol. 2024. PMID: 39530519 Free PMC article.
-
Identification of a senescence-related transcriptional signature to uncover molecular subtypes and key genes in hepatocellular carcinoma.PLoS One. 2024 Oct 9;19(10):e0311696. doi: 10.1371/journal.pone.0311696. eCollection 2024. PLoS One. 2024. PMID: 39383169 Free PMC article.
-
An Examination of Liver Cancer Incidence in California.J Registry Manag. 2024 Winter;51(4):136-145. J Registry Manag. 2024. PMID: 40109759 Free PMC article.
References
-
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries | Enhanced Reader. - PubMed
-
- Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al.. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet. 2018;391: 1023–1075. doi: 10.1016/S0140-6736(17)33326-3 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical